ScreenerHero
EAPIEUROAPI SA
EPA · FR · Healthcare · Drug Manufacturers - Specialty & Generic · euroapi.com
0.9820EUR0.00%Mkt Cap: 101.49M $P/E: —

Euroapi S.A. develops, manufactures, markets, and distributes active pharmaceutical ingredients and intermediates used in the formulation of medicines for human and veterinary use in France, Europe, Rest of Europe, North…

Industry Peers

Drug Manufacturers - Specialty & Generic
Screen all
MRK
MERCK Kommanditgesellschaft auf Aktien
$65.24BUSDP/E 23.7
HLN
Haleon plc American Depositary Shares (Each representing two Ordinary Shares)
$43.41BUSDP/E 20.1
ZOE
Zoetis Inc.
$29.37BUSDP/E 12.4
UTHR
United Therapeutics Corporation
$22.70BUSDP/E 19.0
VTRS
Viatris, Inc.
$18.66BUSD
SOBI
Swedish Orphan Biovitrum AB
$15.39BUSDP/E 118.0
NBIX
Neurocrine Biosciences, Inc.
$15.81BUSDP/E 22.8
IPN
Ipsen S.A.
$14.67BUSDP/E 26.5
ELAN
Elanco Animal Health Incorporat
$12.24BUSD
KRK
Krka, d. d.
$8.57BUSDP/E 18.8
HIMS
Hims & Hers Health, Inc.
$7.25BUSD
LQDA
Liquidia Corporation
$6.74BUSDP/E 53.8
LNTH
Lantheus Holdings Inc
$6.56BUSDP/E 24.0
AMRX
Amneal Pharmaceuticals, Inc.
$6.23BUSDP/E 37.3
INDV
Indivior PLC Ordinary Shares
$4.61BUSDP/E 14.0
HIK
Hikma Pharmaceuticals PLC
$4.32BUSDP/E 12.5
AMLX
Amylyx Pharmaceuticals Inc. Common Stock
$4.30BUSD
SFZN
Siegfried Holding AG
$3.91BUSDP/E 20.4
ROVI
Laboratorios Farmaceuticos Rovi, S.A.
$3.34BUSDP/E 16.6
SUPN
Supernus Pharmaceuticals, Inc.
$2.82BUSD

Key Statistics

Company
Market Cap101.49M $
Enterprise Value163.40M $
Revenue (TTM)863.70M $
Gross Profit157.39M $
Net Income (TTM)-229.57M $
Revenue/Share9.115 USD
Last Price0.9820 EUR
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees3.0K
CountryFR
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISINFR0014008VX5
Valuation
P/E (Trailing)—
P/E (Forward)-7.05
PEG—
EV/EBITDA1.14
EV/Revenue0.19
P/S0.12
P/B0.20
EPS (TTM)-2.23
EPS (Forward)-0.14
52W Range
0.92302% of range3.438
52W High3.438 EUR
52W Low0.9230 EUR
Profitability
Gross Margin16.98%
Oper. Margin-2.86%
EBITDA Margin16.63%
Profit Margin-24.77%
ROE-26.80%
ROA-16.19%
Growth
Revenue Growth-14.00%
Earnings Growth—
Cash Flow & Leverage
Operating CF139.67M $
CapEx (TTM)85.33M $
FCF Margin19.21%
FCF Yield163.47%
Net Debt61.96M $
Net Debt/EBITDA0.43
Balance Sheet
Debt/Equity0.08
Current Ratio2.01
Quick Ratio0.53
Book Value/Sh4.899 EUR
Cash/Share0.5440 EUR
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 EUR
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)1.150 EUR
Upside (mean)+17.1%
Target Range0.7000 EUR – 1.700 EUR
€0.7000+17.1% to mean€1.700
# Analysts4
Ownership
Shares Out.95.57M
Float50.80M
Insiders34.84%
Institutions35.99%
Technical
SMA 501.188 (-17.4%)
SMA 2001.762 (-44.3%)
Beta0.96
S&P 52W Chg18.16%
Avg Vol (30d)170.27K
Avg Vol (10d)131.18K
Technical Indicators
RSI (14)33.8
MACD-0.0690
MACD Signal-0.0733
MACD Hist.+0.0044
BB Upper1.259 EUR
BB Middle1.039 EUR
BB Lower0.8190 EUR
BB Width42.38%
ATR (14)0.0444 EUR
Vol Ratio (20d)0.47x